TELA logo

TELA Bio (TELA)

Profile

Full Name

TELA Bio, Inc.

Ticker Symbol

TELA

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

November 8, 2019

Indexes

Not included

Website

http://www.telabio.com

Employees

209

Key Details

Price

$1.06(+4.95%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$69.30M(+18.56% YoY)

Annual EPS

-$1.33(+34.80% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.06
TELA price is $1.06

30-Day Relative Volume

1.08
TELA 30-day relative volume is 1.08

Price Performance

Price Today change

+4.95%
TELA price is up +4.95% today

Price YTD change

-64.9%
TELA price is down -64.9% since January 1st

Price 1-year change

-77.45%
TELA price is down -77.45% year-on-year

Price 3-year change

-89.4%
TELA price is down -89.4% over the past 3 years

Price Range

Price All-time high

$23.55
TELA price is currently -95.50% below its historical high of $23.55

Price 3-year low

$0.86
TELA price is currently +22.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$41.92M
TELA market capitalization is $41.92 million

Market cap 3-year change

-71.2%
TELA market capitalization is down -71.2% over the past 3 years

Market cap All-time high

$278.45M
TELA market capitalization is currently -84.94% below its historical high of $278.45 million

Market cap sector rank

35.61%
TELA market capitalization is higher than 35.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+60.43%
TELA shares outstanding is up +60.43% year-on-year

Shares Outstanding 3-Year Change

+171.7%
TELA shares outstanding is up +171.7% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.93
TELA beta is 0.93

200-day SMA

$2.88
TELA price is currently -63.17% below its 200-day simple moving average

50-day SMA

$2.07
TELA price is currently -48.74% below its 50-day simple moving average

RSI

27.16
TELA 14-day relative strength index is 27.16

Volume

1.08
TELA 30-day relative volume is 1.08

ATR

$0.14
TELA average true range is $0.14

10-day Historical Volatility

108.81%
TELA 10-day historical volatility is 108.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$69.30M
TELA annual revenue is $69.30 million

Revenue Analysts estimate

$85.54M
TELA annual revenue is currently -18.98% lower than the consensus analysts' forecast

Revenue 1-year change

+18.56%
TELA annual revenue is up +18.56% year-on-year

Revenue Sector rank

51.62%
TELA annual revenue is higher than 51.62% of companies in Healthcare sector

EPS

EPS

-$1.33
TELA annual earnings per share is -$1.33

EPS Analysts estimate

-$0.68
TELA annual earnings per share is currently +97.04% higher than the consensus analysts' forecast

EPS 1-year change

+34.8%
TELA annual earnings per share is up +34.8% year-on-year

EPS Sector rank

48.88%
TELA annual earnings per share is higher than 48.88% of companies in Healthcare sector

Profit

Gross profit

$46.49M
TELA annual gross profit is $46.49 million

Gross margin

67.08%
TELA annual gross profit margin is 67.08%

Operating profit

-$41.70M
TELA annual operating income is -$41.70 million

Operating margin

-60.17%
TELA annual operating profit margin is -60.17%

Net income

-$37.84M
TELA annual net profit is -$37.84 million

Net margin

-54.60%
TELA annual net profit margin is -54.60%

Expenses

Total expenses

$111.00M
TELA annual total expenses is $111.00 million

Operating expenses

$88.18M
TELA annual total operating expenses is $88.18 million

Cost of goods sold

$22.81M
TELA annual cost of goods sold is $22.81 million

Selling, general & administrative expenses

$79.37M
TELA annual SGA is $79.37 million

Depreciation and amortization

$1.01M
TELA annual depreciation & amortization is $1.01 million

Interest expense

$5.29M
TELA annual interest expense is $5.29 million

Income tax

-$144.00K
TELA annual income tax is -$144.00 thousand

EBIT & EBITDA

EBIT

-$32.70M
TELA annual earnings before interest & taxes is -$32.70 million

EBITDA

-$31.68M
TELA annual EBITDA is -$31.68 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$86.57M
TELA annual total assets is $86.57 million

Non current assets

$8.50M
TELA annual long term assets is $8.50 million

Current assets

$78.07M
TELA annual total current assets is $78.07 million

Cash and cash equivalents

$52.67M
TELA annual cash & cash equivalents is $52.67 million

Accounts receivable

$10.10M
TELA annual accounts receivable is $10.10 million

Inventory

$12.78M
TELA annual inventory is $12.78 million

Liabilities

Total liabilities

$58.11M
TELA annual total liabilities is $58.11 million

Long term liabilities

$42.51M
TELA annual total long term liabilities is $42.51 million

Current liabilities

$15.60M
TELA annual total current liabilities is $15.60 million

Accounts payable

$2.15M
TELA annual accounts payable is $2.15 million

Debt

Total debt

$41.67M
TELA annual total debt is $41.67 million

Total debt 1-year change

+1.43%
TELA annual total debt is up +1.43% year-on-year

Long term debt

$41.12M
TELA annual long term debt is $41.12 million

Short term debt

$545.00K
TELA annual short term debt is $545.00 thousand

Equity & Capital

Shareholders equity

$28.46M
TELA annual stockholders equity is $28.46 million

Book value

$28.46M
TELA annual book value is $28.46 million

Retained earnings

-$358.73M
TELA annual retained earnings is -$358.73 million

Working capital

$62.47M
TELA annual working capital is $62.47 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$41.59M
TELA annual cash flow from operations is -$41.59 million

Cash from operations 1-year change

-1.81%
TELA annual cash flow from operations is down -1.81% year-on-year

Cash from investing

$4.45M
TELA annual cash flow from investing activities is $4.45 million

Cash from investing 1-year change

+843.07%
TELA annual cash flow from investing activities is up +843.07% year-on-year

Cash from financing

$43.06M
TELA annual cash flow from financing activities is $43.06 million

Cash from financing 1-year change

-6.94%
TELA annual cash flow from financing activities is down -6.94% year-on-year

CAPEX

CAPEX

$989.00K
TELA annual capital expenditures is $989.00 thousand

CAPEX 1-year change

+61.87%
TELA annual capital expenditures is up +61.87% year-on-year

Free Cash Flow

Free cash flow

-$42.58M
TELA annual free cash flow is -$42.58 million

Free cash flow 1-year change

-2.69%
TELA annual free cash flow is down -2.69% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

67.08%
TELA annual gross profit margin is 67.08%

Operating margin

-60.17%
TELA annual operating profit margin is -60.17%

Net margin

-54.60%
TELA annual net profit margin is -54.60%

ROA & ROE

ROA

-45.97%
TELA annual return on assets is -45.97%

ROE

-159.87%
TELA annual return on equity is -159.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TELA price to earnings ratio value is unknown

PE ratio Sector rank

-
TELA price to earnings ratio is unknown

PB Ratio

PB ratio

1.47
TELA price to book ratio is 1.47

PB ratio Sector rank

53.91%
TELA price to book ratio is higher than 53.91% of companies in Healthcare sector

PS Ratio

PS ratio

0.60
TELA price to sales ratio is 0.60

PS ratio Sector rank

19.23%
TELA price to sales ratio is higher than 19.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$30.92M
TELA enterprise value is $30.92 million

Enterprise value Sector rank

35.7%
TELA enterprise value is higher than 35.7% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.98
TELA EV/EBITDA is -0.98

EV/EBITDA Sector rank

43.57%
TELA EV/EBITDA is higher than 43.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.01
TELA annual current ratio is 5.01

Quick ratio

4.19
TELA annual quick ratio is 4.19

Leverage

Debt to equity

1.45
TELA annual debt to equity ratio is 1.45

Interest coverage ratio

-6.18
TELA annual interest coverage ratio is -6.18

Risk & Stability

Piotroski F-Score

2
TELA piotroski f-score is 2

Altman Z-Score

-4.95
TELA altman z-score is -4.95

Analyst ratings

Recent major analysts updates

Mar 21, 25 Piper Sandler
Neutral
Mar 21, 25 Citizens Capital Markets
Market Outperform
Mar 21, 25 Canaccord Genuity
Buy
Nov 8, 24 Piper Sandler
Overweight
Oct 4, 24 Canaccord Genuity
Buy
Aug 13, 24 Piper Sandler
Overweight
Aug 13, 24 Lake Street
Buy
Aug 13, 24 JMP Securities
Market Outperform
Aug 13, 24 Canaccord Genuity
Buy
Jul 25, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

Advanced Biomed (ADVB)
APYX logo
Apyx Medical (APYX)
RPTX logo
Repare Therapeutics (RPTX)
ANTX logo
AN2 Therapeutics (ANTX)
NVNO logo
enVVeno Medical (NVNO)
Pheton Holdings Ltd Class A (PTHL)
SKYE logo
Skye Bioscience (SKYE)
DXR logo
Daxor (DXR)
OPGN logo
OpGen (OPGN)
  • What is the ticker symbol for TELA Bio?
  • Does TELA Bio pay dividends?
  • What sector is TELA Bio in?
  • What industry is TELA Bio in?
  • What country is TELA Bio based in?
  • When did TELA Bio go public?
  • Is TELA Bio in the S&P 500?
  • Is TELA Bio in the NASDAQ 100?
  • Is TELA Bio in the Dow Jones?
  • When was TELA Bio's last earnings report?
  • When does TELA Bio report earnings?
  • Should I buy TELA Bio stock now?

What is the ticker symbol for TELA Bio?

The ticker symbol for TELA Bio is NASDAQ:TELA

Does TELA Bio pay dividends?

No, TELA Bio does not pay dividends

What sector is TELA Bio in?

TELA Bio is in the Healthcare sector

What industry is TELA Bio in?

TELA Bio is in the Medical Devices industry

What country is TELA Bio based in?

TELA Bio is headquartered in United States

When did TELA Bio go public?

TELA Bio's initial public offering (IPO) was on November 8, 2019

Is TELA Bio in the S&P 500?

No, TELA Bio is not included in the S&P 500 index

Is TELA Bio in the NASDAQ 100?

No, TELA Bio is not included in the NASDAQ 100 index

Is TELA Bio in the Dow Jones?

No, TELA Bio is not included in the Dow Jones index

When was TELA Bio's last earnings report?

TELA Bio's most recent earnings report was on Mar 20, 2025

When does TELA Bio report earnings?

The next expected earnings date for TELA Bio is May 9, 2025

Should I buy TELA Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page